Sun Pharma signs non-exclusive patent licensing agreement with Takeda for introducing Novel Gastrointestinal Drug, Voltapraz (Vonoprazan) in India Read more
Indian domestic formulations market expected to more than double, comfortably crossing INR 5.5 trillion by 2034: Avendus Capital Read more
Beacon Therapeutics’ AGTC-501 holds potential to become first gene therapy in XLRP space: GlobalData Read more